ArticleAnemia2015

The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients.

Omar Maoujoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.